Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Jacobs

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Canadian Respiratory Journal|June 26, 2019
Corrigendum to "Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada"Nguyen Xuan Thanh, Philip Jacobs, Jason Suggett, et al.
Diabetes Research and Clinical Practice|August 30, 2005
Socio-economic status and undiagnosed diabetesRonald P Wilder, Sumit R Majumdar, Scott W Klarenbach, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 3, 2019
Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, CanadaDat T Tran, Ilke Akpinar, Irvin Mayers, et al.
Palliative Medicine|October 20, 2009
Costs associated with resource utilization during the palliative phase of care: a Canadian perspectiveSerge Dumont, Philip Jacobs, Konrad Fassbender, et al.
Palliative Medicine|November 22, 2005
Utilization and costs of the introduction of system-wide palliative care in Alberta, 1993-2000Konrad Fassbender, Robin Fainsinger, Carleen Brenneis, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|July 25, 2013
Potential impacts of the Alberta fetal alcohol spectrum disorder service networks on secondary disabilities: a cost-benefit analysisNguyen Xuan Thanh, Jessica Moffatt, Philip Jacobs, et al.
Drugs - Real World Outcomes|October 18, 2016
Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003-2008)Arianna Waye, Anderson W Chuck, Philip Jacobs, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|January 15, 2014
A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitalsPhilip Jacobs, Douglas Lier, Katherine Gooch, et al.
Annals of Emergency Medicine|January 7, 2003
Cost-effectiveness of a brief two-stage emergency department intervention for high-risk elders: results of a quasi-randomized controlled trialJane McCusker, Philip Jacobs, Nandini Dendukuri, et al.
Journal of the American Geriatrics Society|December 11, 2002
Older persons in the emergency medical care systemJane McCusker, Josée Verdon, Gideon A Caplan, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Canadian Respiratory Journal|June 26, 2019
Corrigendum to "Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada"Nguyen Xuan Thanh, Philip Jacobs, Jason Suggett, et al.
Diabetes Research and Clinical Practice|August 30, 2005
Socio-economic status and undiagnosed diabetesRonald P Wilder, Sumit R Majumdar, Scott W Klarenbach, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 3, 2019
Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, CanadaDat T Tran, Ilke Akpinar, Irvin Mayers, et al.
Palliative Medicine|October 20, 2009
Costs associated with resource utilization during the palliative phase of care: a Canadian perspectiveSerge Dumont, Philip Jacobs, Konrad Fassbender, et al.
Palliative Medicine|November 22, 2005
Utilization and costs of the introduction of system-wide palliative care in Alberta, 1993-2000Konrad Fassbender, Robin Fainsinger, Carleen Brenneis, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|July 25, 2013
Potential impacts of the Alberta fetal alcohol spectrum disorder service networks on secondary disabilities: a cost-benefit analysisNguyen Xuan Thanh, Jessica Moffatt, Philip Jacobs, et al.
Drugs - Real World Outcomes|October 18, 2016
Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003-2008)Arianna Waye, Anderson W Chuck, Philip Jacobs, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|January 15, 2014
A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitalsPhilip Jacobs, Douglas Lier, Katherine Gooch, et al.
Annals of Emergency Medicine|January 7, 2003
Cost-effectiveness of a brief two-stage emergency department intervention for high-risk elders: results of a quasi-randomized controlled trialJane McCusker, Philip Jacobs, Nandini Dendukuri, et al.
Journal of the American Geriatrics Society|December 11, 2002
Older persons in the emergency medical care systemJane McCusker, Josée Verdon, Gideon A Caplan, et al.
Pageof 14